Human BRCA1-BARD1 Ubiquitin ligase activity counters chromatin barriers to DNA resection

The opposing activities of 53BP1 and BRCA1 influence pathway choice of DNA double-strand break repair. How BRCA1 counters the inhibitory effect of 53BP1 on DNA resection and homologous recombination is unknown. Here we identify the site of BRCA1-BARD1 required for priming ubiquitin transfer from E2~ubiquitin. We demonstrate that BRCA1-BARD1’s ubiquitin ligase activity is required for repositioning 53BP1 on damaged chromatin. We confirm H2A ubiquitylation by BRCA1-BARD1 and show that an H2A-ubiquitin fusion protein promotes DNA resection and repair in BARD1 deficient cells. We show BRCA1-BARD1 function in homologous recombination requires the chromatin remodeler SMARCAD1. SMARCAD1 binding to H2A-ubiquitin, optimal localization to sites of damage and activity in DNA repair requires its ubiquitin-binding CUE domains. SMARCAD1 is required for 53BP1 repositioning and the need for SMARCAD1 in Olaparib or camptothecin resistance is alleviated by 53BP1 loss. Thus BRCA1BARD1 ligase activity and subsequent SMARCAD1-dependent chromatin remodeling are critical regulators of DNA repair.

[1]  P. Cejka,et al.  DNA End Resection: Nucleases Team Up with the Right Partners to Initiate Homologous Recombination* , 2015, The Journal of Biological Chemistry.

[2]  R. Greenberg,et al.  Deciphering the BRCA1 Tumor Suppressor Network* , 2015, The Journal of Biological Chemistry.

[3]  D. Durocher,et al.  MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5′ end-resection , 2015, Nature.

[4]  Peter Bouwman,et al.  REV7 counteracts DNA double-strand break resection and affects PARP inhibition , 2015, Nature.

[5]  David J. Chen,et al.  PTIP associates with Artemis to dictate DNA repair pathway choice , 2014, Genes & development.

[6]  P. Huertas,et al.  BRCA1 accelerates CtIP-mediated DNA-end resection. , 2014, Cell reports.

[7]  Stéphanie Panier,et al.  Double-strand break repair: 53BP1 comes into focus , 2013, Nature Reviews Molecular Cell Biology.

[8]  I. Hickson,et al.  A role for BLM in double-strand break repair pathway choice: prevention of CtIP/Mre11-mediated alternative nonhomologous end-joining. , 2013, Cell reports.

[9]  A. Shibata,et al.  Co-operation of BRCA1 and POH1 relieves the barriers posed by 53BP1 and RAP80 to resection , 2013, Nucleic acids research.

[10]  M. Hendzel,et al.  A Small Molecule Inhibitor of Polycomb Repressive Complex 1 Inhibits Ubiquitin Signaling at DNA Double-strand Breaks* , 2013, The Journal of Biological Chemistry.

[11]  Danny T. Huang,et al.  Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3 , 2013, Nature Structural &Molecular Biology.

[12]  Dustin E. Schones,et al.  The ATP-dependent Chromatin Remodeling Enzyme Fun30 Represses Transcription by Sliding Promoter-proximal Nucleosomes* , 2013, The Journal of Biological Chemistry.

[13]  Adam P. Rosebrock,et al.  A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. , 2013, Molecular cell.

[14]  R. Aebersold,et al.  A DNA-Damage Selective Role for BRCA1 E3 Ligase in Claspin Ubiquitylation, CHK1 Activation, and DNA Repair , 2012, Current Biology.

[15]  James E. Haber,et al.  The Saccharomyces cerevisiae Chromatin Remodeler Fun30 Regulates DNA End Resection and Checkpoint Deactivation , 2012, Molecular and Cellular Biology.

[16]  S. Jackson,et al.  BRCA1-associated exclusion of 53BP1 from DNA damage sites underlies temporal control of DNA repair , 2012, Journal of Cell Science.

[17]  Agnès Thierry,et al.  The yeast Fun30 and human SMARCAD1 chromatin remodelers promote DNA end resection , 2012, Nature.

[18]  Hong Wu,et al.  A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2. , 2012, Cancer cell.

[19]  J. Walter,et al.  A novel function for BRCA1 in crosslink repair. , 2012, Molecular cell.

[20]  K. Khanna,et al.  Exo1 plays a major role in DNA end resection in humans and influences double-strand break repair and damage signaling decisions. , 2012, DNA repair.

[21]  Peter Bouwman,et al.  BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance. , 2011, Cancer cell.

[22]  F. Gage,et al.  BRCA1 tumor suppression occurs via heterochromatin mediated silencing , 2011, Nature.

[23]  J. Naismith,et al.  Mechanism of ubiquitylation by dimeric RING ligase RNF4 , 2011, Nature Structural &Molecular Biology.

[24]  T. Sixma,et al.  Symmetry and asymmetry of the RING-RING dimer of Rad18. , 2011, Journal of molecular biology.

[25]  D. Oxley,et al.  Maintenance of silent chromatin through replication requires SWI/SNF-like chromatin remodeler SMARCAD1. , 2011, Molecular cell.

[26]  Olivia Barton,et al.  Role of ATM and the Damage Response Mediator Proteins 53BP1 and MDC1 in the Maintenance of G2/M Checkpoint Arrest , 2010, Molecular and Cellular Biology.

[27]  Jeremy M. Stark,et al.  53BP1 Inhibits Homologous Recombination in Brca1-Deficient Cells by Blocking Resection of DNA Breaks , 2010, Cell.

[28]  T. Owen-Hughes,et al.  The Snf2 Homolog Fun30 Acts as a Homodimeric ATP-dependent Chromatin-remodeling Enzyme* , 2010, The Journal of Biological Chemistry.

[29]  J. Miller,et al.  The SNF2-Family Member Fun30 Promotes Gene Silencing in Heterochromatic Loci , 2009, PloS one.

[30]  T. Ludwig,et al.  E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks , 2008, Proceedings of the National Academy of Sciences.

[31]  Oliver Weichenrieder,et al.  Structure and E3‐ligase activity of the Ring–Ring complex of Polycomb proteins Bmi1 and Ring1b , 2006, The EMBO journal.

[32]  T. Katagiri,et al.  Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility. , 2006, Human molecular genetics.

[33]  N. Curtin,et al.  Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM , 2004, Cancer Research.

[34]  T. Ohta,et al.  Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Hurley,et al.  A ubiquitin‐binding motif required for intramolecular monoubiquitylation, the CUE domain , 2003, The EMBO journal.

[36]  J. Bartek,et al.  Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage , 2003, Nature Cell Biology.

[37]  C. Vandenberg,et al.  Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains , 2002, The EMBO journal.

[38]  N. Keep,et al.  Identification of Residues Required for the Interaction of BARD1 with BRCA1* , 2002, The Journal of Biological Chemistry.

[39]  C. Boutell,et al.  Herpes Simplex Virus Type 1 Immediate-Early Protein ICP0 and Its Isolated RING Finger Domain Act as Ubiquitin E3 Ligases In Vitro , 2002, Journal of Virology.

[40]  Rachel E. Klevit,et al.  Structure of a BRCA1–BARD1 heterodimeric RING–RING complex , 2001, Nature Structural Biology.

[41]  J. Pruneda,et al.  RING-type E3 ligases: master manipulators of E2 ubiquitin-conjugating enzymes and ubiquitination. , 2014, Biochimica et biophysica acta.

[42]  D. Mallery,et al.  University of Dundee BRCA 1 is a histone-H 2 A-specific ubiquitin ligase , 2014 .